Area: Cardiology
Location: Chicago, United States
Date: November 10 to November 12
Description:
Scientific Sessions of the American Heart Association.
Endoscopic Vein Harvest for Coronary Bypass Surgery in a Randomized Multicenter Trial With Long-Term Follow-Up - REGROUP Trial
U.S. HHS’ Physical Activity Guidelines for Americans
The Cardiovascular Inflammation Reduction Trial (CIRT): Low Dose Methotrexate for the Prevention of Atherosclerotic Events
Effectiveness of a Yoga-Based Cardiac Rehabilitation (yoga-care) Program: A Multi-Centre Randomised Controlled Trial of 4,014 Patients With Acute Myocardial Infarction From India
Withdrawal of Pharmacological Heart Failure Therapy in Recovered Dilated Cardiomyopathy - A Randomised Controlled Trial (TRED-HF)
Angiotensin Receptor-Neprilysin Inhibition in Patients Hospitalized With Acute Decompensated Heart Failure: Primary Results of the PIONEER-HF Randomized Controlled Trial
2018 Cholesterol Guidelines - What's New in the Guidelines?
The Primary Results of the REDUCE-IT Trial
The VITamin D and OmegA-3 TriaL (VITAL): Principal Results for Vitamin D and Omega-3 Fatty Acid Supplementation in the Primary Prevention of Cardiovascular Disease and Cancer
The Primary result of the (DECLARE)-TIMI 58 Trial
Blood plessure in older adults
Effects of Rivaroxaban on Thrombotic Events in Heart Failure Patients With Coronary Disease and Sinus Rhythm
Early Goal-Directed Hemodynamic Optimization in Comatose Survivors After Out-of-Hospital Cardiac Arrest: The Neuroprotect Trial
2018 AHA/ACC Cholesterol Clinical Practice Guidelines
Increasing awareness of Peripheral Artery Disease
EMPA-HEART Cardiolink-6 Trial: A Randomized Trial Evaluating the Effect of Empagliflozin on Left Ventricular Structure, Function and Biomarkers in People With Type 2 Diabetes and Coronary Heart Disease
Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial
TiCAB: A Randomized, Double-Blind Study of Ticagrelor versus Aspirin in Patients Undergoing Coronary Bypass Surgery
A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Multicenter Clinical Trial of Low-Dose Adjunctive Alteplase During Primary PCI (T-TIME)
Discussant: EWTOPIA75
Commentary about the TRED-HF Trial: Withdrawal of Pharmacological Heart Failure Therapy in Recovered Dilated Cardiomyopathy
Top messages of the new Cholesterol Guidelines
The Primary results of the PIONEER Trial
Commentary on the TRED-HF and the PIONEER-HF Trials